“By combining our efforts, we will bring more advanced, accurate, and relevant DNA tests quicker across the globe, which ultimately means many more dogs and owners will have better relationships. We look forward to working with the team at Genoscoper going forward”, says Neale Fretwell, General Manager of Mars Veterinary. 

“Genoscoper and Mars Veterinary share mutual interests and future visions for advancing animal health and welfare. Our partnership is a clear demonstration not only of Genoscoper’s expertise and dedication but also of the high quality of Finnish DNA technology in general. For Genoscoper, this is an important step on our path of becoming the leading DNA diagnostics company for all companion animals”, says Tuomas Poskiparta, Director of Genoscoper Laboratories.

Mars Veterinary is a business unit of Mars Petcare, the U.S. operations of the world’s largest pet care company at the privately held Mars, Incorporated. Its mission is facilitating responsible pet care by enhancing the well-being and relationship between pets, pet owners and veterinarians through valuable insights into pets as individuals. For nearly a decade as part of Mars Symbioscience, Mars Veterinary has researched and developed state-of-the-art genetic tests for mixed-breed dogs, revolutionizing personalized pet care. By discovering a mixed-breed dog’s ancestry, pet owners and veterinarians can work together to tailor wellness programs that fit the one-of-a-kind needs of a mixed-breed dog.

Genoscoper Laboratories is a Finland-based animal diagnostics laboratory established in 1995. Its MyDogDNA testing concept helps explore inherited characteristics in dogs using the world’s first genome-wide DNA analysis. The technology uses a comprehensive panel analysis to test for known mutations, and simultaneously records thousands of neutral chromosomal markers that can be used to measure genetic diversity and even locate new mutations associated with other genetic disorders.

Back to transactions